Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
Homare OkamuraMamoru ArakawaAtsushi MiyagawaHideo AdachiPublished in: General thoracic and cardiovascular surgery (2019)
A transdermal bisoprolol patch is an effective and safe β-blocker drug delivery system. The incidence of POAF in this group was lower than that in users of oral bisoprolol.
Keyphrases
- atrial fibrillation
- angiotensin converting enzyme
- risk factors
- left ventricular
- minimally invasive
- patients undergoing
- spinal cord
- aortic valve
- left atrial
- pulmonary artery
- direct oral anticoagulants
- catheter ablation
- oral anticoagulants
- spinal cord injury
- venous thromboembolism
- percutaneous coronary intervention
- pulmonary arterial hypertension
- surgical site infection